by Alison Bass | Jun 11, 2009 | Uncategorized
As Congress steps up its efforts to craft a comprehensive health care reform bill, Senator Edward Kennedy (in absentia) is leading the charge for a public health insurance option that can compete with private insurers. As far as I can tell, this would not only involve...
by Alison Bass | Jun 1, 2009 | Uncategorized
Much has been written about prominent doctors who fail to disclose their lucrative financial ties with pharmaceutical and medical device companies. Yet there has been less focus on hospitals and other leading institutions who have similar conflicts of interest —...
by Alison Bass | May 28, 2009 | Uncategorized
In order to truly stabilize the economy and rescue Medicare from financial collapse, the Obama administration knows it has to do something about the elephant in the room: ever-rising health care costs. In this week’s New Yorker, surgeon-writer Atul Gawande...
by Alison Bass | May 20, 2009 | Uncategorized
On his Pharma Marketing blog today, John Mack recaps the controversy over the patient who was paid hundreds of thousands of dollars by Bristol Myers Squibb to promote Abilify and then changed his tune. (Andy Behrman, aka “Electroboy,” began talking out...
by Alison Bass | May 14, 2009 | Uncategorized
I had the pleasure of speaking to a large group of senior citizens yesterday at a Jewish community center in the Boston area. I had been invited there to talk about Side Effects, and while the focus of my talk (like my book) was how drug companies deceived the...
by Alison Bass | May 7, 2009 | Uncategorized
As The Boston Globe’s unions vote on whether to bow to the inevitable and make the financial concessions demanded to keep their newspaper alive, it seems a sad but apropos time to bring attention to a new survey on the declining state of health care journalism....
